News & Publications
The latest company updates and clinical data
Press Releases
amplifAI health partners with USATherm in a Saudi-US Alliance to Advance Thermographic Applications in Healthcare
Riyadh, Saudi Arabia | September 3, 2024 – amplifAI health is pleased to announce our partnership with USATherm, a renowned innovator in point-of-care thermal imaging technology. This strategic partnership aims to combine the expertise of both companies to set a new standard in diagnostic capabilities and disease monitoring. The partnership marks the beginning of a collaboration that merges amplifAI’s advanced AI software with USATherm’s advanced thermal imaging cameras. By integrating…
FDA Approves Cutting-Edge Thermal Imaging Device, Revolutionizing Healthcare and Beyond
FORT LAUDERDALE FL., September 14, 2023 – USATherm, a leading innovator in the field of medical thermal imaging technology, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted a 510(k) on it’s 2nd generation thermal imaging device. ThermPix™ leverages cutting-edge thermal imaging technology to provide high-resolution, real-time thermal images of the human body. This non-invasive and non-ionizing imaging device has the potential to transform the…
USATherm Receives FDA Clearance for the ThermPix™ Point of Care Infrared Thermography Camera
AVENTURA, FL., May 31, 2022 – USATherm, a healthcare technology company specializing in the development of AI-assisted infrared thermography diagnostic devices to improve the quality and efficiency of medical imaging, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ThermPix™ Point of Care Infrared Thermography (POCIT) adjunctive diagnostic camera. ThermPix™ is an infrared thermovisual camera with proprietary software that is designed…
Publications
Thermal Imaging of Superficial Leg Circulation Improves Venous Diagnostic Efficiency and Completeness
VASCULAR DISEASE MANAGEMENT 2020;17(11):E208-E211.
Thermal imaging (TI) has been used in the medical field for over 50 years; however, it has shown limited clinical utility partly due to prohibitive costs, size, and often its use in inappropriate disease states. In this single center retrospective analysis, the impact of thermal imaging of legs was assessed by comparing complete duplex ultrasound (DUS) diagnostic results before and after the addition of TI to the routine clinical evaluation.
Sensitivity and Specificity of Thermal Imaging When Used to Detect Superficial Venous Reflux as Compared to Duplex Ultrasound
VASCULAR DISEASE MANAGEMENT 2021;18(3):E45-E49
More than 80 million Americans suffer from chronic venous disease (CVD), which often is visually recognized as varicose veins.1 If left untreated, these abnormal leg veins can progressively worsen and cause other complications.2 Thus, optimizing non-contact, noninvasive imaging methods that can be useful in either earlier or more complete diagnosis of CVD may be beneficial.
Thermal Imaging Positioned to Become the Best Tool in the Evaluation of Superficial Venous Insufficiency
VASCULAR DISEASE MANAGEMENT® Volume 18, No. 3, March 2021
Welcome to the March 2021 edition of Vascular Disease Management. There are many articles of great interest in this month’s edition. I have chosen to comment on Dr. Ariel Soffer and colleagues’ article “Sensitivity and Specificity of Thermal Imaging When Used to Detect Superficial Venous Reflux as Compared to Duplex Ultrasound.”